Nicholas Kitchin

9PUBLICATIONS
22CO-AUTHORS
Immunogenetics (incl. genetic immunology)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Evolution of developmental systemsInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 27, 2026
Safety and Immunogenicity of the BNT162b2 COVID-19 Vaccine in Immunocompromised Participants 2 Years and Older: Results of an Open-Label Phase 2b Study.

|Jul 22, 2026
Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV.

|May 25, 2026
Randomized Phase 3 Comparison of a 2-Dose and 3-Dose Regimen of a Detoxified Toxin A/B Clostridioides difficile Vaccine in Adults 50 Years and Older.

|Jan 21, 2026
Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old.

Patricia Winokur, Oyeniyi Diya, David Fitz-Patrick

|Dec 08, 2025
T-cell Response Induced by the BNT162b2 COVID-19 Vaccine in Children.

Isabel Vogler, Stephanie Renken, Rolf Hilker

|May 07, 2025
A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults.

Angela Branche, Mark J Mulligan, Alok Maniar

Pageof 2

Frequent Collaborators

4 joint publications

Kena A Swanson

3 joint publications

Stephen P Lockhart

3 joint publications

William C Gruber

1 joint publications

Xuping Xie